论文部分内容阅读
本文在用PGE_1治疗肝硬化患者过程中,测定 了治疗前后其血浆TXB_2、6-K-PGF_(1α)浓度,现将结果报道如下。 对象和方法 一、对象:住院经病史询问、体检、实验室检查、 B超、CT等检查确诊的乙型肝炎后肝硬化70例,随 机分为两组,组Ⅰ为对照组30例(男22,女8),年龄 24.5～72岁,平均49.8岁。按Child分级:A级8例,B 级12例,C级10例。组Ⅱ为实验组40例(男30,女10), 年龄25～71岁,平均51.3岁。按Child分级:A级10 例,B级20例,C级10例。两组病人均无心血管疾病, 血清Cr、BUN测定在正常范围,无上消化道出血情 况。另选择30例健康人作正常对照。
This article in the treatment of patients with liver cirrhosis with PGE_1, measured before and after treatment of plasma TXB_2, 6-K-PGF_ (1α) concentrations, the results reported below. Subjects and Methods 1, Subjects: 70 patients with post-hepatitis B cirrhosis diagnosed by physical examination, physical examination, laboratory examination, B-ultrasound and CT were randomly divided into two groups. GroupⅠwas 30 cases in control group 22, female 8), aged 24.5 to 72 years, an average of 49.8 years old. According to Child classification: A grade in 8 cases, B grade in 12 cases, C grade in 10 cases. Group Ⅱ was 40 in the experimental group (30 males and 10 females), aged from 25 to 71 years, with an average of 51.3 years. Classification by Child: A grade in 10 cases, B grade in 20 cases, C grade in 10 cases. Two groups of patients without cardiovascular disease, serum Cr, BUN measured in the normal range, no upper gastrointestinal bleeding. Another 30 healthy people as normal control.